Remove Leads Remove Networking Remove Physicians Remove Safety
article thumbnail

ReCor Medical Announces Two Concurrent JAMA Network Publications of Study Results on the Paradise Ultrasound Renal Denervation System for the Treatment of Hypertension

Legacy MEDSearch

In addition, pooled analysis results from the combined primary efficacy endpoint and safety data from RADIANCE SOLO, RADIANCE TRIO, and RADIANCE II were concurrently published in JAMA Cardiology. The study also achieved its primary safety composite outcome with no major adverse events observed. mmHg, compared to a reduction of -1.8

article thumbnail

Leading patient adherence pharmaceutical companies

Pharmaceutical Technology

Discover the leading patient adherence pharmaceutical companies. The companies offer various products and services for diverse operations including, but not limited to, consulting, clinical, medical affairs, regulatory affairs, analytics, safety, marketing, and customer experience.

Leads 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Using data analytics to better manage care transitions

Clarify Health

Poor care transition management can lead to fragmented healthcare delivery, often leading to increased patient readmissions, compromised health outcomes, and elevated costs. By actively managing transitions, hospitals can reduce the likelihood of adverse events, improve patient safety, and enhance overall healthcare quality.

article thumbnail

Implementation of electronic health records will improve the quality of care

Pharmaceutical Technology

It can also lead to more personalised treatment approaches and lay a stronger foundation for value-based care. According to the same report, physicians from the UK, Spain and China were the most positive about the ability of EHRs to increase patients’ quality of care.

article thumbnail

Why Is FDA Issuing Fewer Marketing Violation Letters?

Pharma Marketing Network

As new healthcare challenges arise and the pharmaceutical landscape evolves, the FDA may be allocating its resources to focus on other pressing issues, such as drug approvals, monitoring emerging health threats, and enhancing drug safety. appeared first on Pharma Marketing Network.

article thumbnail

Creating Synergy: Aligning Brand Values with High-Impact Healthcare Sponsorships in the Pharmaceutical Industry 

Pharma Marketing Network

For example, Pfizer, a leading pharmaceutical company, has a long history of sponsoring research into new drugs and treatments. For example, Merck, another leading pharmaceutical company, has a website that provides information about a variety of health conditions.

article thumbnail

Precision-based Targeting: A Better Way to Connect with Patients and Healthcare Professionals

LEVO Health

Unlike traditional methods, this approach allows for messaging that resonates on a personal level , leading to improved engagement and outcomes. The campaign could segment HCP audiences into various groups, such as endocrinologists, primary care physicians, and diabetes specialists.